Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis

Hepato-Gastroenterology

Volumn 57, Issue 104, 2010, Pages 1375-1381

  Carr, Brian I ^a   Irish, William ^b   Federle, Michael P ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CTI   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemoembolization; PVT; Responses; Survival; TACE

Indexed keywords

ALPHA FETOPROTEIN; CEFAZOLIN; CISPLATIN; DECARBOXYPROTHROMBIN; DEXAMETHASONE; GAMMA GLUTAMYLTRANSFERASE; MORPHINE SULFATE; VANCOMYCIN;

ADULT; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT RESPONSE;

BIOPSY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 79952381791     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576. (Pubitemid 46890874)
2. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD: Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009;3:353-367.
3. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;July 10 EPub.
4. Bosch FX, Ribes, J, Diaz M, Cleries R: Primary liver cancer: Worldwide Incidence and Trends. Gastroenterology 127:S5-S16, 2004. (Pubitemid 39423365)
5. Lopez PM, Villanueva A and Llovet JM: Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Alimentary Pharmacol. Ther. 2006: 23: 1535-1547
6. Lencioni R: Loco-Regional treatment of hepatocellular carcinoma Hepatology 2010; April 19. Epub
7. Pleguezuelo M, Marelli L, Misseri M, Germani G, Calvaruso V, Xiruochakis E, Pinelopi M, Burroughs A: TACE versus TAE as therapy for hepatocellular carcinoma. Expert Review of Anti-Cancer Therapy 2008;8:1623-1641.
8. Shin SW: The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 2009;10:425-434.
9. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch D, Burroughs A: Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007;30:6-25. (Pubitemid 44900485)
10. Lo C, Ngan H, Tso WK, et al: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171. (Pubitemid 34454013)
11. Llovet J, Real M, Montana X, et al: Arterial embolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;359:1734-1739. (Pubitemid 34607087)
12. Jeon SH, Park KS, Kim YH, Shin YS, Kang MK, Jang BK, Chung WJ, Cho KB, Hwang JS: Incidence and risk factors of acute hepatic failure after transcatheter chemoembolization for hepatocellular carcinoma. Korean J. Gastroenterol. 2007 ; 50 : 176-182
13. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiiology 1983; 148 : 397-401
14. Minagawa M, Makuuchi M: Treatment of hepatocellular carcinoma accompanied by portal vein thrombus. World J. Gastroenterol. 2006 ; 12 : 7561-7567
15. Carr BI, Kondragunta V, Buch S, Branch R: Therapeutic equivalence in survival for hepatic arterial chemoembolization and 90Yttrium microspheres (Y90) treatments in unresectable HCC. Cancer 2010; 116: 1305-1314.
16. Okazaki M, Higashihara H, Koganemaru HE: Transcatheter arterial embolization for inoperable hepatocellular carcinoma. Jpn J Clin Radiol 1991; 36: 535-539
17. Chung JW, Park JH, Han JK, Choi BI, Han MC: Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR Am J Roentgenol 1995; 165: 315-321
18. Georgiades CS, Hong K, D'Angelo M, Geschwind JF: Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 2005; 16: 1653-1659 (Pubitemid 44431162)
19. Carr BI: Hepatic artery chemoembolization for advanced stage HCC: experience with 650 patients. Hepatogastroenterology 2002; 49: 79-86
20. Dodd GR, Carr BI: Percutaneous biopsy of portal vein thrombus: A new staging technique for hepatocellular carcinoma. Am J Radiol 1993; 161: 229-233.
21. Tarantino L, Francica G, Sordelli I, Esposito F, Giorgio A, Sorrentino P, de Stefano G, Di Sarno A, Ferraioli G, Sperlongano P: Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging. 2006;31(5):537-44. (Pubitemid 46360843)
22. Piscaglia F, Gianstefani A, Ravaioli M, Golfieri R, Cappelli A, Giampalma E, Sagrini E, Imbriaco G, Pinna AD, Bolondi L: Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl. 2010; 16: 658-667
23. Kaplan El, Meier P: Nonparametric estimation from incomplete observations. Journal of the American Statistical Society 1958: 53: 457-481
24. Mantel N: Evaluation of survival data and two new rank order statistics arising its consideration. Cancer Chemotherapy Reports 1966:50:163-170
25. Cox DR: Regression models and life tables. Journal of the Royal Statistical Society Series B 1972:34: 187-220.
26. Carr BI and Nagalla S: Medical therapy of HCC.in Hepatocellual Carcinoma (Carr BI -ed),Human Press 2010. Pp589-568
27. Yen FS, Wu JC, Kuo BI, Chiang JH, Chen TZ, Lee SD: Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis. J Gastroenterol Hepatol. 1995;10:237-40.
28. Chung YH, Song IH, Song BC, Lee GC, Koh MS, Yoon HK, Lee YS, Sung KB, Suh DJ: Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer. 2000 May 1;88(9):1986-91.
29. Chen TM, Chang TM, Huang PT, Tsai MH, Lin LF, Liu CC, Ho KS, Siauw CP, Chao PL, Tung JN: Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter? J Gastroenterol Hepatol. 2008;23:179-88.
30. Nomura F, Ohnishi K, Tanabe Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 1989;60:1700-7. (Pubitemid 19251142)
31. Low AFP HCC. Carr BI, Pancoska P, Branch RA: J. Gastroenterol. Hepatol. 2010 (in press).
32. Pancoska P, Carr BI, Branch RA: Network-based analysis for survival for unresectable hepatocellular carcinoma. Seminars in oncology 2010; 37: 170-181
33. Utsonomiya T, Shimada M, Imura S, Morine Y, Ikemoto T and Mori M: Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J. Gastroenterol. 2010: 45: 146-152
34. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR: Gene expression in fixed tissues and outcome in hepatocellular carcinoma.N Engl J Med. 2008 Nov 6;359(19): 1995-2004